The first influenza pandemic of the 21st century

Annals of Saudi Medicine

Volumn 30, Issue 1, 2010, Pages 1-10

  Al Hajjar, Sami ^a   McIntosh, Kenneth ^b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; BISMUTH SALICYLATE; CORTICOSTEROID; HYPERTENSIVE FACTOR; IBUPROFEN; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; OSELTAMIVIR; PARACETAMOL; ZANAMIVIR;

ABDOMINAL PAIN; ADULT RESPIRATORY DISTRESS SYNDROME; AGE DISTRIBUTION; ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; ASIAN INFLUENZA; AVIATION; BACTERIAL INFECTION; CHEMOPROPHYLAXIS; CHILD; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; DIARRHEA; DRUG FATALITY; DRUG MEGADOSE; FATALITY; GUILLAIN BARRE SYNDROME; HONG KONG INFLUENZA; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; LOW DRUG DOSE; MULTIPLE ORGAN FAILURE; NAUSEA; NAUSEA AND VOMITING; NONHUMAN; PANDEMIC; PNEUMONIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; REYE SYNDROME; SEPTIC SHOCK; SPANISH INFLUENZA; VIRUS DIAGNOSIS; VIRUS GENE; VIRUS MUTATION; VIRUS PNEUMONIA; VIRUS STRAIN; VIRUS TRANSMISSION; VOMITING; WORLD HEALTH ORGANIZATION;

ANIMALS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; PANDEMICS; SWINE; WORLD HEALTH; ZOONOSES;

EID: 77249162207     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.4103/0256-4947.59365     Document Type: Review

References (73)

1. Beveride, WIB. The chronicle of influenza epidemics. Hist Phil Life Sci 1991;223-235
2. Johnson NP, Muller J. Updating the accounts: Global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med 2002;76:105-115
3. Monto AS. Implications of antiviral resistance of influenza viruses. (Comment) Clin Infect Dis. 2009;48(4):389-396
4. Besselaar TG, Naidoo D, Buys A, et al. Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa. Emerg Infect Dis 2008;14:1809-1810
5. Chen CW, Shih SR. Generic signatures of influenza A pandemic (H1N1) 2009 virus. Emerg Infect. Dis. 2009;15(12):1897-1903
6. Balkhy H, Al-Hajjar S. Avian influenza: are our feathers ruffled? Ann Saudi Med. 2006 May-Jun;26(3):175-182
7. Poland GA. Vaccine against avian influenza. A race against time. N Engl J Med 2006;354(13):1411-1413
8. Dowdle WR. Influenza A virus cycling revisited. Bull World Health Organ 1999; 77:820-828
9. Foucher RA, Munster V, Wallensten A, etal. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from block headed gulls. J Virol 2005; 79:2814-2822
10. Ferguson NM, Galvani AP, Bush RM. Ecological and immunological determinants of influenza evolution. Nature 2003;442:428-433
11. Webster RG, Hulse DJ. Microbial adaptation and change: avian influenza. Rev Sci Tech 2004;23:453-465
12. Guan T, Poon LL, Cheum CY, et al. H5N1 influenza: a protean pandemic threat. Proc Natl Acad Sci USA 2004;101(21):8156-8161
13. Reid AH, Fanning TG, Hultin JV, et al. Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene. Proc Natl Acad Sci USA 1999;96:1651-1656
14. Kawaoka Y, Krauss S, Webster RG. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemic. J Virol 1989;63(11):4603-4608
15. Morens DM, Taubenberger JK, Fanci AS. The persistent legacy of the 1918 influenza virus. N England J Med 2009; 361(3):225-229
16. Koen J. A practical method for field diagnoses of swine diseases. Am J Vet Med 1919;14:468-470
17. Shope RE. Swine Influenza, J Exp Med 1931; 54:373-385
18. Vincent AL, Lager KM, Ma W, Lekcharoensuk P, Framer MR, Loicano C, et al. Evaluation of hemagglutinin subtype 1 swine influenza viruses from the United States. Bet Microbiol 2006; 118:212-222
19. Gaydos JC, Top FH, Hiddler RA. Swine influenza A outbreak, Fort Dix, New Jersey 1976. Emerg Infect. Dis 2006; 12(1):23-28
20. Shortridge KF, Webster RG. Butterfield WK. Persistent of Hong Kong influenza virus variants in pigs. Science 1977; 196:1454-1455
21. Zhou NN, Senne DA, Landgraf JS, Swenson SL, Erickson G, Rossow K, et al. Genetic reassortment of avian, swine, and human influenza A viruses in American pigs. J Virol 1999;73:8851-8856
22. Van Reeth K. Avian and swine influenza viruses: our current understanding of the zoonotic risk. Vet Res 2007;38:243-260
23. Gray GC, Trampel DW, Roth JA. Pandemic influenza planning: shouldn't swine and poultry workers be included? Vaccine 2007;25:4376-4381
24. Myers KP, Olsen CW, Gray GC. Cases of swine influenza in humans: a review of the literature. Clin Infect Dis 2007;44:1084-1088
25. Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, Xu X, et al. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005 - 2009. N Engl J Med. 2009;360(25):2616-2625.
26. Zhang H, Chen L. Possible origin of current influenza A H1N1 viruses on The Lancet 2009; 9:456-457
27. Trifonov V, Khiabanian H, Rabadan R. Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus. N Engl J Med. 2009 Jul 9;361(2):115-119
28. Itoh Y, Shinya K, Kiso M et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009; 460(20): 1021-1025
29. Peiris JS, Poon LL, Guan Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol 2009 Jul;45(3):169-173
30. Centers for Disease Control and Prevention (CDC). Human Infection with new influenza A (H1N1) virus: Mexico, update March - May 2009. Wkly Epidemiol Rec 2009;84:213-219
31. Update: swine influenza A (H1N1) infections - California and Texas, April 2009. MMWR Morb Mortal Wkly Rep 2009;58:435-437
32. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-2615
33. Pandemic (H1N1) 2009 - update77. Geneva: World Health Organization, 2009. Accessed 4 December 2009 at http://www.who.int/csr/don/2009-12-04/en/index.html
34. Khan K, Aumo J. Hu W et al. Spread of novel influenza A (H1N1) virus via global airline transportation. N Engl J Med 2009; 361:212-214
35. World now at the start of 2009 Influenza pandemic. http://www.who.int/ mediacentre/news/statements/2009/h1n1-pandemic-phase6-20090601
36. WHO. Pandemic influenza A (H1N1) 2009 virus. Weekly epidemiological record 2009; 84(49):505-516.
37. Fisman Dv, Savage R, Gubbay, et al. Older age and reduced likehood of 2009 H1N1 virus infection. N Engl Med 2009; 361-2000-2001.
38. Hancok K, Veguilla V, Lu X. Et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945-1952.
39. Ynag Y, Sugimoto JD, Halloran ME, et al. The transmissibility and control of pandemic influenza A (H1N1) virus. Science 2009; 326:729-733.
40. United States Centers for Disease Control and Prevention. Interim guidance on antiviral recommendations for patients with novem influenza A (H1N1) virus infection and their close contacts. http://www.cdc.gov/h1n1flu/ recommendatins.htm (accessed 07 May 2009)
41. United States Centers for Disease Control and Prevention. Interim guidance for clinician identifying and caring for patients with swine-origin influenza A (H1N1) virus infection http://www.cdc.gov/ swinefluidentifyingpatients.htm (acessed on May 5, 2009).
42. United States Centers for Disease Control and Prevention. Interim guidance on infection control measures for 2009 H1N1 influenza in healthcare settings, including protection of healthcare personnel. http://cdc.gov/h1n1flu/ guidelines-infection.htm.
43. United States Centers for Disease Control and Prevention. Weekly 2009 H1N1. Flu media briefing. http://www.cdc.gov/media/transcripts/2009/t091023.htm. (accessed 23 October 2009)
44. WHO. Weekly Epidemiological Record. Human infection with new influenza A (H1N1) virus: clinical observation from Mexico and other affected countries. 2009; 84(21):185-196.
45. Hacketts, Hill L, Patel J, et al. Clinical characteristics of pediatric H1N1 admissions in Birmingham, UK. The Lancet 2009;374,605-606.
46. United States Centers of Disease Control and Prevention. Updated interim recommendation from the use of antiviral treatment and prevention of influenza from 2009-2010 season. http://www.cdc.gov/h1n1 flu/recommednations.htm. (accessed on December 7, 2009).
47. Jain, S, Kamimoto, L, Bramley, AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl Med 2009; 361:1935.
48. Louie, JK, Acosta, M, Winter, K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA 2009; 302:1986.
49. Surveillance for pediatric deaths associated with 2009 pandemic influenza a (H1N1) virus infection. United States, April- August 2009 MMWR Morb Morta Wkly Rep. 2009;58(34)
50. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009 Aug 13;361(7):680-689
51. Dominguez-Cherit, Lapinsky, SE, Macias, AE, et al. Critically Ill patients with 2009 influenza A (H1N1) in Mexico. JAMA 2009; 302:1880-1887.
52. Davies, A, Jones, D, Bailey, M, et al. Extracorporeal Membrane Oxygenation for 2009 Infleunza A (H1N1) Acute Respiratory Distress Syndrome. JAMA 2009; 302:1888-1895.
53. Webb, SA, Pettila, V, Seppelt, I, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N. Engl J Med 2009; 361:1-10
54. Kumar, A, Zarychanski, R, Pinto, et al. Critically ill patients with 2009 Influenza A (H1N1) infection in Canada. JAMA; 302:1872-1879.
55. Bacterial coninfections in lung tissue specimen from fatal cases of 2009 pandemic influenza A (H1N1)-United States, May- August 2009. MMWR; 58 *early Release):1-4
56. Neurologic complications associated with novel influenza A (H1N1) vitus infection in children- Dallas, Texas, May 2009. MMWR Morb Mortal Wkly Rep 2009; 58-773-778.
57. Fraser C, Dannelly CA, Cauchernez S, et al. Pandemic potential of a strain of influenza A (H1N1): Eraly finding. Science. 2009;324(5934):1557-1560
58. Vaillant L, La Ruche G, Tarantola A, et al. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. (Rapid Communication) Euro Surveill 2009;14(33). pii: 19309
59. 59. United States Centers for Disease Control and Prevention. Interim Recommedations for Clinical Use of Influenza Diagnostic Tests During the 2009-10 Influenza Season. http://www.cdc.gov/h1n1/guidance/diagnostic-tests.htm (acessed December 2, 2009).
60. Centers for infections disease research and policy. Novel H1N1 influenza (swine flu). http://www.cidrap.iniv.edu/cidropcontent/influenza/biofacts/ swinefluoverview.html. (accessed December 6, 2009).
61. European center for disease prevention and control. Oseltamivir-resistant pandemic (H1N1) 2009 influenza virus. October 2009. http://www.ecdc.europa.eu/ en/activities/sciadvice/tests. (accessed December 10, 2009).
62. United States Centers for Disease Control and Prevention. Antiviral treatment oprions including intravenous peramivir for treatment of influenza in hospitalized patients for 2009-2010 season. http://www.cdc.gov/H1N1flu/EUA/ Peramovir-recommednations.html. (accessed on 2 December 2009)
63. Kidd IM, Nastouli E, Shulmam R, et al. H1N1 pneumonitis treated with intravenous zanamivir (case report). www.thelancet.com 2009;374:1036.
64. Intensive care patients, with severe novel influenza A (H1N1) virus infections. Michigan, June 2009. MMWR 2009; 58 (dispotech):1-4.
65. Gomez-Gomez A, Magana-Auno M, Garcia-Sepulveada CA, et al. Severe pneumonia associated with pandemic (H1N1) 2009 outbreak. Emerg Infect Dis. 1020 Jan:(e-pub ahead of print).
66. United States Centre for Disease Control and Prevention. Interim guidance on infection control measures for 2009 H1N1 influenza in health care setting, including protection health care personnel. http://www.cdc.gov/h1n1flu/ guidelines-infection-control.htm (accessed December 6, 2009).
67. Global alert and response: Pandemic (H1N1) 2009. Geneva: World Health Organization, 2009 (accessed September 10, 2009, at http://www.who.int/csr/ disease/swineflu/en).
68. Ferguson NM, Cummings DA, Fraser C, Cajka, JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. Nature 2006;442:448-452
69. Safety of pandemic vaccines (Pandemic (H1N1) briefing note 16:WHO 2009 (accessed 1 December 2009) at http://www.who.int/csr/disease/swineflu/notes/ briefing-2009119/en.
70. United States cCenter of Disease Control and Prevention:2009 H1N1 vaccination recommendation. http://wwwcdc.gov.h1n1flu/vaccination/acip/htm. (accessed December 4, 2009)
71. Use of influenza A (H1N1) 2009 monovalent vaccine. MMWR 2009;58:18.
72. Zhu Fe, Fang HH, Yan JG, et al. A novel influenza A (H1N1) vaccine in various groups. N Engl Med 2009; 361:1-10.
73. Clark TW, Pareek M, Hoschlerk, et al. Trial of Influenza A (H1N1) 2009 monovalent MF59-adjvanted vaccine-preliminary report. N Engl Med 2009; 361:1-11.